Ubs Asset Management Americas Inc Apellis Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 222,634 shares of APLS stock, worth $3.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
222,634
Previous 212,887
4.58%
Holding current value
$3.77 Million
Previous $6.79 Million
28.32%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$208 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$207 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$201 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$172 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$163 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $1.86B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...